4.2 Article

POSTCONDITIONING HORMESIS PUT IN PERSPECTIVE: AN OVERVIEW OF EXPERIMENTAL AND CLINICAL STUDIES

期刊

DOSE-RESPONSE
卷 9, 期 2, 页码 209-224

出版社

SAGE PUBLICATIONS INC
DOI: 10.2203/dose-response.10-004.Wiegant

关键词

hormesis; postconditioning; postexposure; adaptive response; preconditioning

向作者/读者索取更多资源

A beneficial effect of applying mild stress to cells or organisms, that were initially exposed to a high dose of stress, has been referred to as 'postconditioning hormesis'. The initial high dose of stress activates intrinsic self-recovery mechanisms. Modulation of these endogenous adaptation strategies by administration of a subsequent low dose of stress can confer effects that are beneficial to the biological system. Owing to its potentially therapeutic applications, postconditioning hormesis is subject to research in various scientific disciplines. This paper presents an overview of the dynamics of postconditioning hormesis and illustrates this phenomenon with a number of examples in experimental and clinical research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Acute HIV-1 infection is as common as malaria in young febrile adults seeking care in coastal Kenya

Eduard J. Sanders, Peter Mugo, Henrieke A. B. Prins, Elizabeth Wahome, Alexander N. Thiong'o, Grace Mwashigadi, Elisabeth M. van der Elst, Anisa Omar, Adrian D. Smith, Susan M. Graham

Meeting Abstract Immunology

Engaging Young Adult Clients of Retail Pharmacies for HIV-1 Testing in Coastal Kenya

Peter M. Mugo, Henrieke Prins, Elizabeth Wahome, Grace Mwashigadi, Alexander Thiong'o, Evanson Gichuru, Anisa Omar, Susan M. Graham, Eduard J. Sanders

AIDS RESEARCH AND HUMAN RETROVIRUSES (2014)

Article Multidisciplinary Sciences

Effect of Text Message, Phone Call, and In-Person Appointment Reminders on Uptake of Repeat HIV Testing among Outpatients Screened for Acute HIV Infection in Kenya: A Randomized Controlled Trial

Peter M. Mugo, Elizabeth W. Wahome, Evanson N. Gichuru, Grace M. Mwashigadi, Alexander N. Thiong'o, Henrieke A. B. Prins, Tobias F. Rinke de Wit, Susan M. Graham, Eduard J. Sanders

PLOS ONE (2016)

Article Infectious Diseases

Engaging young adult clients of community pharmacies for HIV screening in Coastal Kenya: a cross-sectional study

Peter M. Mugo, Henrieke A. B. Prins, Elizabeth W. Wahome, Grace M. Mwashigadi, Alexander N. Thiong'o, Evanson Gichuru, Anisa Omar, Susan M. Graham, Eduard J. Sanders

SEXUALLY TRANSMITTED INFECTIONS (2015)

Review Public, Environmental & Occupational Health

Diagnosing acute and prevalent HIV-1 infection in young African adults seeking care for fever: a systematic review and audit of current practice

Henrieke A. B. Prins, Peter Mugo, Elizabeth Wahome, Grace Mwashigadi, Alexander Thiong'o, Adrian Smith, Eduard J. Sanders, Susan M. Graham

INTERNATIONAL HEALTH (2014)

Article Virology

Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA

Cynthia Lungu, Francesco A. Procopio, Ronald J. Overmars, Rob J. J. Beerkens, Jolanda J. C. Voermans, Shringar Rao, Henrieke A. B. Prins, Casper Rokx, Giuseppe Pantaleo, David A. M. C. van de Vijver, Tokameh Mahmoudi, Charles A. B. Boucher, Rob A. Gruters, Jeroen J. A. van Kampen

VIRUSES-BASEL (2020)

Article Infectious Diseases

The dolutegravir/valproic acid drug-drug interaction is primarily based on protein displacement

P. D. J. Bollen, H. A. B. Prins, A. Colbers, K. Velthoven-Graafland, B. J. A. Rijnders, T. E. M. S. De Vries-Sluijs, E. van Nood, J. Nouwen, H. Bax, M. de Mendonca Melo, A. Verbon, D. M. Burger, C. Rokx

Summary: This study confirms protein displacement as the main mechanism for the dolutegravir/valproic acid drug-drug interaction, although additional mechanisms might be involved too. If dolutegravir is taken with food, this drug-drug interaction is probably not clinically relevant.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Multidisciplinary Sciences

Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir

Shringar Rao, Cynthia Lungu, Raquel Crespo, Thijs H. Steijaert, Alicja Gorska, Robert-Jan Palstra, Henrieke A. B. Prins, Wilfred van Ijcken, Yvonne M. Mueller, Jeroen J. A. van Kampen, Annelies Verbon, Peter D. Katsikis, Charles A. B. Boucher, Casper Rokx, Rob A. Gruters, Tokameh Mahmoudi

Summary: This study demonstrates the selective induction of cell death in latent HIV-1-infected cells by DDX3 inhibitors, and provides evidence for the reduction of the inducible HIV-1 reservoir in CD4+ T cells from PLWHIV. The pharmacological targeting of DDX3 shows promise in reversing HIV-1 latency and eliminating the latent reservoir.

NATURE COMMUNICATIONS (2021)

Editorial Material Immunology

Launching a multidisciplinary European collaboration towards a cure for HIV: The EU2Cure Consortium

C. Rokx, H. A. B. Prins, L. Vandekerckhove, S. J. Fidler, J. Frater, M. Bracchi, O. S. Sogaard, M. Tolstrop, T. A. Rasmussen, M. Salgado, J. Blanco, J. Martinez-Picado, B. Clotet, G. Tambussi, A. Groenendijk, A. Verbon, C. A. B. Boucher

Summary: The EU2Cure Consortium aims to support research and find a cure for HIV through collaboration in Europe, connecting academia and the community. The focus is on intensifying research collaboration, sharing data, and developing best practices for clinical and translational science to achieve breakthroughs in HIV cure strategies. This strategy should help sustain progress in HIV cure research despite global health or political crises.

JOURNAL OF VIRUS ERADICATION (2021)

Article Medicine, General & Internal

Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospective cohort study of people with acute or early HIV infection who immediately initiate HIV treatment

Maartje Dijkstra, Henrieke Prins, Jan M. Prins, Peter Reiss, Charles Boucher, Annelies Verbon, Casper Rokx, Godelieve de Bree

Summary: The study focuses on individuals with early HIV infection who start combination antiretroviral therapy (cART) with the aim of investigating the size of the viral reservoir and HIV-specific immune responses in preparation for future HIV cure trials.

BMJ OPEN (2021)

Article Immunology

HIV transmission among acutely infected participants of a Dutch cohort study 2015-2021 is not associated with large, clustered outbreaks

Henrieke A. B. Prins, Casper Rokx, Annelies Verbon, Ard van Sighem, Godelieve J. de Bree, Maartje Dijkstra, Jan M. Prins, Peter Reiss, Jeroen J. A. van Kampen, David A. M. C. van de Vijver

Summary: Timely identification of acute or early HIV infection is crucial for prevention of onward transmission. This study investigated a sample of individuals with AEHI in the Netherlands and identified transmission clusters, suggesting mainly independent transmission events.
Article Infectious Diseases

Outbreak of imported diphtheria with Corynebacterium diphtheriae among migrants arriving in Germany, 2022

Franziska Badenschier, Anja Berger, Alexandra Dangel, Annika Sprenger, Bernhard Hobmaier, Claudia Sievers, Henrieke Prins, Achim Doerre, Christiane Wagner-Wiening, Wiebe Kuelper-Schiek, Ole Wichmann, Andreas Sing

EUROSURVEILLANCE (2022)

Article Infectious Diseases

Exposure and virologic outcomes of dolutegravir combined with ritonavir boosted darunavir in treatment-naive individuals enrolled in the Netherlands Cohort Study on Acute HIV infection (NOVA)

H. A. B. Prins, L. Zino, E. M. Svensson, A. Verbon, G. J. de Bree, J. M. Prins, P. Reiss, D. M. Burger, C. Rokx, A. Colbers

Summary: This study evaluated the dose adjustment of dolutegravir (DTG) when co-administered with darunavir/ritonavir (DRV/r) in patients with acute human immunodeficiency virus infection (AHI). The results showed that DTG 50 mg twice daily with DRV/r 800/100 mg once daily achieved satisfactory outcomes without significant clinically relevant drug-drug interactions in patients with AHI.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

Article Multidisciplinary Sciences

The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy

Henrieke A. B. Prins, Raquel Crespo, Cynthia Lungu, Shringar Rao, Letao Li, Ronald J. Overmars, Grigorius Papageorgiou, Yvonne M. Mueller, Mateusz Stoszko, Tanvir Hossain, Tsung Wai Kan, Bart J. A. Rijnders, Hannelore I. Bax, Eric C. M. van Gorp, Jan L. Nouwen, Theodora E. M. S. de, Carolina A. M. Schurink, Mariana de Mendonca Melo, Els van Nood, Angela Colbers, David Burger, Robert-Jan Palstra, Jeroen J. A. van Kampen, David A. M. C. van de Vijver, Thibault Mesplede, Peter D. Katsikis, Rob A. Gruters, Birgit C. P. Koch, Annelies Verbon, Tokameh Mahmoudi, Casper Rokx

Summary: The BAF complex inhibitor pyrimethamine can reactivate the latent HIV-1 reservoir in people living with HIV-1 (PLWH) on suppressive antiretroviral therapy, but does not lead to a reduction in the size of the inducible reservoir.

SCIENCE ADVANCES (2023)

Review Medicine, General & Internal

Ending the epidemic: Critical role of primary HIV infection

H. A. B. Prins, A. Verbon, C. A. B. Boucher, C. Rokx

NETHERLANDS JOURNAL OF MEDICINE (2017)

暂无数据